LON:BGS Baillie Gifford Shin Nippon (BGS) Share Forecast, Price & News GBX 147.20 +1.90 (+1.31%) (As of 06/5/2023 ET) Add Compare Share Share Today's Range 145▼ 14850-Day Range 139.20▼ 154.2052-Week Range 131.32▼ 168.04Volume348,825 shsAverage Volume524,709 shsMarket Capitalization£462.21 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsInsider TradesHeadlinesOptions ChainProfileChartCompetitorsInsider TradesHeadlinesOptions Chain About Baillie Gifford Shin Nippon (LON:BGS) StockBaillie Gifford Shin Nippon PLC is a closed-ended equity mutual fund launched and managed by Baillie Gifford & Co Ltd. It is co-managed by Baillie Gifford & Co. The fund invests in the public equity markets of Japan. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in value and growth stocks of small-cap companies having market capitalizations less than Yen 150 billion. It benchmarks the performance of its portfolio against the Tokyo Second Section Index, the TOPIX Small Index, and the JASDAQ Index. Baillie Gifford Shin Nippon PLC was formed on July 1, 1985 and is domiciled in the United Kingdom.Read More Receive BGS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Baillie Gifford Shin Nippon and its competitors with MarketBeat's FREE daily newsletter. Email Address BGS Stock News HeadlinesMarch 26, 2023 | americanbankingnews.comBaillie Gifford Shin Nippon (LON:BGS) Stock Crosses Below 50 Day Moving Average of $156.55February 25, 2023 | wsj.comShin Nippon Biomedical Laboratories Ltd.June 5, 2023 | Behind the Markets (Ad)The single greatest medical breakthrough of all time?We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.February 22, 2023 | cnbc.comBaillie Gifford Shin NipponJanuary 25, 2023 | nasdaq.comBaillie Gifford & Co Cuts Stake in EverQuote, Inc. Class A (EVER)January 14, 2023 | benzinga.com'Baillie Gifford admits 'humbling year' after $14bn loss on Tesla and Shopify' -Financial TimesOctober 13, 2022 | theguardian.comFemale history and biography writing dominates Baillie Gifford shortlistOctober 13, 2022 | theguardian.comFemale history and biography writing dominates Baillie Gifford shortlistJune 5, 2023 | Behind the Markets (Ad)The single greatest medical breakthrough of all time?We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.September 22, 2022 | foxnews.comKathie Lee Gifford urges Janice Dean to forgive Andrew Cuomo after reports his team plotted to discredit herJune 19, 2022 | thetimes.co.ukI backed the wonder material that would change the world . . . but no one wants itSeptember 3, 2021 | investing.comBaillie Gifford Shin Nippon PLC (BGS)September 2, 2020 | uk.finance.yahoo.comWhat Next for Japan?May 20, 2020 | www.fool.co.ukBaillie Gifford Shin Nippon (LSE:BGS)December 24, 2019 | www.lse.co.ukBaillie Gifford Shin Nippon Hires Ex-Standard Life Investments ManagerSeptember 30, 2019 | www.lse.co.ukBaillie Gifford Shin Nippon PLC Share ChatSeptember 17, 2019 | www.lse.co.ukBaillie Gifford Shin Nippon PLC Regulatory NewsSee More Headlines BGS Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Industry, Sector and Symbol Stock ExchangeLON Industry Asset Management Sub-IndustryN/A SectorFinance Current SymbolLON:BGS CUSIPN/A CIKN/A Webwww.bailliegifford.com Phone+44-80-09172112FaxN/AEmployees3,207Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-7,040,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-1.28% Return on Assets-0.68% Debt Debt-to-Equity Ratio16.14 Current Ratio0.22 Quick Ratio3.66 Sales & Book Value Annual Sales£-3,130,000.00 Price / Sales-148.06 Cash FlowGBX 1.05 per share Price / Cash Flow141.21 Book ValueGBX 174 per share Price / Book0.85Miscellaneous Outstanding Shares314,000,000Free FloatN/AMarket Cap£463.44 million OptionableOptionable Beta0.70 Key ExecutivesMr. Praveen KumarPortfolio Mang.Key CompetitorsAsia Dragon TrustLON:DGNPolar Capital Global Financials TrustLON:PCFTUtilico Emerging Markets TrustLON:UEMBH GlobalLON:BHGGMid Wynd International Investment TrustLON:MWYView All Competitors BGS Stock - Frequently Asked Questions How have BGS shares performed in 2023? Baillie Gifford Shin Nippon's stock was trading at GBX 153.70 at the beginning of the year. Since then, BGS stock has decreased by 4.0% and is now trading at GBX 147.59. View the best growth stocks for 2023 here. What other stocks do shareholders of Baillie Gifford Shin Nippon own? Based on aggregate information from My MarketBeat watchlists, some companies that other Baillie Gifford Shin Nippon investors own include Ryanair (RYAAY), Persimmon (PSN), BlackRock World Mining Trust (BRWM), Scottish Mortgage Investment Trust (SMT), The Scottish Oriental Smaller Companies Trust (SST), Redrow (RDW), Allianz Technology Trust (ATT), abrdn Asia Focus (AAS), The Berkeley Group (BKG) and B&M European Value Retail (BME). What is Baillie Gifford Shin Nippon's stock symbol? Baillie Gifford Shin Nippon trades on the London Stock Exchange (LON) under the ticker symbol "BGS." How do I buy shares of Baillie Gifford Shin Nippon? Shares of BGS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Baillie Gifford Shin Nippon's stock price today? One share of BGS stock can currently be purchased for approximately GBX 147.59. How much money does Baillie Gifford Shin Nippon make? Baillie Gifford Shin Nippon (LON:BGS) has a market capitalization of £463.44 million and generates £-3,130,000.00 in revenue each year. The company earns £-7,040,000.00 in net income (profit) each year or GBX (0.02) on an earnings per share basis. How many employees does Baillie Gifford Shin Nippon have? The company employs 3,207 workers across the globe. How can I contact Baillie Gifford Shin Nippon? Baillie Gifford Shin Nippon's mailing address is Calton Square, 1 Greenside Row, EDINBURGH, EH1 3AN, United Kingdom. The official website for the company is www.bailliegifford.com. The company can be reached via phone at +44-80-09172112. This page (LON:BGS) was last updated on 6/5/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Baillie Gifford Shin Nippon PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.